947 related articles for article (PubMed ID: 25368253)
1. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
2. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2012 Oct; 32(10):4375-83. PubMed ID: 23060562
[TBL] [Abstract][Full Text] [Related]
5. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
[TBL] [Abstract][Full Text] [Related]
6. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
7. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
8. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
9. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma.
White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM
Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892
[TBL] [Abstract][Full Text] [Related]
10. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma.
Karamchandani JR; Gabril MY; Ibrahim R; Scorilas A; Filter E; Finelli A; Lee JY; Ordon M; Pasic M; Romaschin AD; Yousef GM
Hum Pathol; 2015 May; 46(5):673-80. PubMed ID: 25704627
[TBL] [Abstract][Full Text] [Related]
11. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
[TBL] [Abstract][Full Text] [Related]
12. [The expression and clinical significance of Annexin II in clear-cell renal cell carcinoma].
Yang J; Cheng TT; Wang LN; Chen W; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):59-62. PubMed ID: 22230505
[TBL] [Abstract][Full Text] [Related]
13. Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma.
Zhuang Q; Qian X; Cao Y; Fan M; Xu X; He X
J Int Med Res; 2014 Apr; 42(2):282-91. PubMed ID: 24514433
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Xue S; Li QW; Che JP; Guo Y; Yang FQ; Zheng JH
Int J Clin Exp Pathol; 2015; 8(4):3765-74. PubMed ID: 26097558
[TBL] [Abstract][Full Text] [Related]
15. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
17. High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma.
Cai MY; Luo RZ; Li YH; Dong P; Zhang ZL; Zhou FJ; Chen JW; Yun JP; Zhang CZ; Cao Y
Biochem Biophys Res Commun; 2012 Oct; 426(4):636-42. PubMed ID: 22982674
[TBL] [Abstract][Full Text] [Related]
18. Tumor biology of non-metastatic stages of clear cell renal cell carcinoma; overexpression of stearoyl desaturase-1, EPO/EPO-R system and hypoxia-related proteins.
Stoyanoff TR; RodrĂguez JP; Todaro JS; Espada JD; Colavita JP; Brandan NC; Torres AM; Aguirre MV
Tumour Biol; 2016 Oct; 37(10):13581-13593. PubMed ID: 27468719
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor-2alpha mRNA expression in human renal cell carcinoma.
Sandlund J; Ljungberg B; Wikström P; Grankvist K; Lindh G; Rasmuson T
Acta Oncol; 2009; 48(6):909-14. PubMed ID: 19322701
[TBL] [Abstract][Full Text] [Related]
20. L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells.
Doberstein K; Wieland A; Lee SB; Blaheta RA; Wedel S; Moch H; Schraml P; Pfeilschifter J; Kristiansen G; Gutwein P
Carcinogenesis; 2011 Mar; 32(3):262-70. PubMed ID: 21097529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]